Artal Group »

Sagimet Biosciences Inc-a shares owned by Artal Group

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Artal Group from 13F filings

Historical chart of Artal Group investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Artal Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Artal Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0M 925k 5.42
2023-09-30 $8.1M 925k 8.80

More positions owned by Artal Group

Cava Group Ord (CAVA)
Scholar Rock Hldg Corp (SRRK)
Lexicon Pharmaceuticals Com New (LXRX)
Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Beigene Sponsored Adr (BGNE)
Kymera Therapeutics (KYMR)
Amicus Therapeutics (FOLD)
Morphic Hldg (MORF)
Springworks Therapeutics (SWTX)
Silence Therapeutics Ads (SLN)
Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Neumora Therapeutics (NMRA)
Arrowhead Pharmaceuticals (ARWR)

View all positions for Artal Group

Top funds holding Sagimet Biosciences Inc-a

NEA Management Company
Baker Bros. Advisors
Hillhouse Capital Advisors
Artal Group
Partner Fund Management
Alyeska Investment Group
Blue Owl Capital Holdings
Vanguard Group
Dumac
AlphaCentric Advisors
Federated Investors
Bank of New York Mellon
Victory Capital Management
Millennium Management
Two Sigma Investments

View all funds holding Sagimet Biosciences Inc-a